|
Funding Agency: National Institutes of Health Title: Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional) Application Deadline: November 07, 2023 The purpose of this Funding Opportunity Announcement (FOA) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs). This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change. This opportunity will allow development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core tenets of the NIHs Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building (https://www.nih.gov/sites/default/files/research-training/initiatives/climate-change/nih-climate-change-framework.pdf). Funding Agency: National Institutes of Health Title: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Application Deadline: Multiple deadlines The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities. Funding Agency: National Institutes of Health Title: Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) Application Deadline: Multiple deadlines This Funding Opportunity Announcement (FOA) invites grant applications aimed at elucidating neuroimmune and neuronal-glial pathophysiological mechanisms of HIV-associated neurological disorders (HAND) using ex vivo culturing platforms derived from human induced pluripotent stem cells (hiPSC) in the presence of addictive substances. Specific emphasis is on unbiased, reproducible analysis of genetics and epigenetics, neuroglial interactions, and neuroimmune cell activities from the single cell to neural circuit levels. Funding Agency: National Institutes of Health Title: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed) Application Deadline: October 25, 2023 This Funding Opportunity Announcement (FOA) provides support to eligible, domestic institutions to develop and implement Postbaccalaureate Research Education Programs in Diabetes, Endocrinology and Metabolic Diseases (DDEMD). These post-baccalaureate research programs will incorporate extensive research experiences and well-designed courses for skills development to prepare recent college graduates from diverse backgrounds to transition into and complete rigorous, research-focused biomedical doctoral degree programs (e.g., Ph.D. or M.D./Ph.D.). The long-term goal of post-baccalaureate participants admitted to the program should be pursuing a career focused on DDEMD-related research. Eligible applicants for the R25 must be research-intensive doctoral degree-granting institutions with a research base in DDEMD science of at least $3 million in direct costs of peer-reviewed research projects, and research opportunities for students admitted to the program must be in DDEMD science. Funding Agency: National Institutes of Health Title: Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required) Application Deadline: May 01, 2023 Care delivery, in which a patients health is viewed apart from their social context, must be reimagined to make meaningful improvements in health, eliminate health disparities, and advance health equity. The purpose of the Bridge-to-Care initiative is to promote research that links clinical care with community services and resources to address unmet social needs and adverse social conditions. More specifically, this funding opportunity invites intervention research studies, conducted in partnership with healthcare and community organizations, that address individuals' and families' unmet social needs and communities' adverse social conditions, with a focus on populations that bear an excess burden of morbidity and mortality. Funding Agency: National Institutes of Health Title: Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed) Application Deadline: October 10, 2023 The purpose of this funding opportunity announcement (FOA) is to encourage research to integrate/harmonize existing large prevention trial data sets implemented earlier in life to examine whether they reduce risk for later suicide, including suicide thoughts and behaviorsfatal and nonfatal (STB), and related external injuries (e.g., nonfatal SUD/OUD/accidents, and all-cause mortality (e.g., National Death Index). This U01 will be competed and funded to: 1) obtain existing prevention trial data sets, with collaboration of the PIs who have the original data sets; 2) anonymize and aggregate and harmonize prevention trial data sets; 3) provide methodological and statistical expertise needed to examine, using theory-based approaches, whether intervening early reduces risk for STB and mortality, and potential mediators and moderators; and 4) oversee a final harmonized prevention trial data that will be deposited into the NIMH Data Archive (NDA). This harmonized dataset will serve as an ongoing resource to the research community for years to come. Funding Agency: National Institutes of Health Title: Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional) Application Deadline: May 01, 2023 Disparities in maternal health outcomes is a public health crisis that requires new insights and solutions. The purpose of this initiative advancing integrated models (AIM) of careis to stimulate research to develop or evaluate supportive care models that address healthcare access or healthcare quality together with structural or social inequities in order to prevent adverse maternal health outcomes among racial and ethnic minority women. This includes original intervention research and research evaluating the impact of federal, tribal, state, local, or organizational policies and programs on maternal health outcomes. Outcomes of interest include pregnancy-related morbidity (e.g., hypertension, diabetes, obesity, cerebrovascular disease, mental illness) including severe maternal morbidity; pregnancy-associated factors (e.g., violence exposure including firearm violence, substance use disorders, dietary patterns), and maternal mortality. Funding Agency: National Institutes of Health Title: Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) Application Deadline: May 01, 2023 The purpose of this FOA is to identify and evaluate the ongoing and long-term impacts of the pandemic era, focusing specifically on governmental (local, state, tribal, federal) policy and programmatic actions that address two specific social determinants of health: food/nutrition security and housing security. Applications are requested to examine how these food/nutrition and housing policies and programs aimed at lessening the effects of the pandemic era impacted health and health equity in individuals, families, and communities from health disparity populations. Health disparity populations include Blacks/African Americans, Hispanics/Latinos, American Indians and Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities. Funding Agency: Food and Drug Administration Title: Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional Application Deadline: May 04, 2023 The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies and/or biomarker studies that fill unmet needs for rare neurodegenerative diseases for children and adults. Through the support of prospective natural history and/or biomarker studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development. Funding Agency: Health Resources and Services Administration Title: Nurse Education, Practice, Quality and Retention (NEPQR)-Pathway to Registered Nurse Program (PRNP) Application Deadline: April 27, 2023 The purpose of this program is to create a pathway from academic training to clinical practice through the creation and implementation of Licensed Practical Nurse/Licensed Vocational Nurse (LPN/LVN) to Registered Nurse (RN) Bridge Programs and employment of Clinical Nurse Faculty. Funding will be used for: • Program Development: Funds can be used to develop and implement or enhance an accredited LPN/LVN-to-RN Bridge program targeting the needs of LPNs/LVNs. • Direct Support for LPN/LVN to RN students: Funds can be used to assist in student success such as stipends, tuition, and other social supports (e.g., transportation and childcare assistance). LPNs/LVNs are nursing professionals and when entering a degree program there may be barriers in place that keep these students from being successful. • Curriculum and Partnership Development: Funds can be used to develop curriculum and build/enhance/maintain partnerships between clinical and educational institutions. Challenges exist for students as they move from one educational institution to another (e.g., academic credits not transferring from 2-year to 4-year institutions) and working experiences are not always counted as credit toward their degree program. Strong partnerships are encouraged between clinical training sites and academic institutions including technical/vocational schools and community colleges to help to mitigate these challenges. • Preceptor/Faculty: Funds can be used to recruit, retain, and develop clinical and didactic faculty and clinical preceptors. Faculty and preceptors are needed to train new students in the bridge program being created. Funding Agency: Congressionally Directed Medical Research Programs Title: Traumatic Brain Injury and Psychological Health Research Program Anticipated Application Deadline: TBD The TBIPHRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY23 funding opportunities. This pre-announcement should not be construed as an obligation by the government. The FY23 TBIPHRP funding opportunity announcements and General Application instructions/General Submission Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.
|
